Global Mofy Metaverse Wins Major New Customer Order
04 mars 2024 09h00 HE
|
Global Mofy Metaverse Limited
Global Mofy Metaverse (Nasdaq: GMM) Wins Major New Customer Order; AI Revolution Driving Accelerated Demand Growth for High-Quality Digital Assets
RegEd Launches Producer Management and Licensing Automation Technology Bundle for Midsized Insurers and Distributors
15 févr. 2024 12h30 HE
|
RegEd
Raleigh, NC, Feb. 15, 2024 (GLOBE NEWSWIRE) -- RegEd, the leading provider of producer management solutions for the insurance and financial services industry, has announced the launch of a...
Numab Therapeutics and Ono Pharmaceutical Announce an Option and Collaboration Agreement to Develop Multi-specific Antibody NM49 for Treatment of Cancer
14 févr. 2024 03h00 HE
|
Numab Therapeutics AG
NM49 is a multi-specific antibody identified through Numab’s proprietary discovery and engineering technology platform designed to activate tumor associated macrophage phagocytosis Numab to receive...
VitalHub Announces First Canadian Licensing Agreement of the Award-Winning Intouch with Health Queue Management & Patient Journey Optimization Platform with Newfoundland & Labrador Health Services
12 févr. 2024 07h30 HE
|
VitalHub Corp.
TORONTO, Feb. 12, 2024 (GLOBE NEWSWIRE) -- VitalHub Corp. (the "Company" or "VitalHub") (TSX:VHI) (OTCQX:VHIBF) is pleased to announce the first Canadian customer for the Intouch with Health Queue...
CryoMass Announces Non-Dilutive Financing Agreement
29 janv. 2024 07h10 HE
|
Cryomass Technologies
CryoMass Announces Non-Dilutive Financing Agreement
Travere Therapeutics Announces Licensing Agreement with Renalys Pharma to Develop and Commercialize Sparsentan in Japan, South Korea, Taiwan, and Southeast Asian Nations
25 janv. 2024 16h05 HE
|
Travere Therapeutics, Inc.
Travere Therapeutics has entered into an exclusive licensing agreement with Renalys Pharma to bring sparsentan to patients in Japan.
TSplus Challenges the One-Size-Fits-All Approach to Licensing Amidst Citrix Policy Changes
12 janv. 2024 09h11 HE
|
TSplus
Amidst Citrix's significant shift towards a subscription-based model, TSplus makes the choice of flexibility when it comes to licensing models.
Henlius and Sermonix Announce Strategic Collaboration and Exclusive License Agreements for Novel Endocrine Therapy Lasofoxifene
10 janv. 2024 19h30 HE
|
Sermonix Pharmaceuticals Inc.
Partnership expands Henlius’ portfolio with license of exclusive China rights to develop, manufacture and commercialize lasofoxifene; Sermonix retains all other global rightsHenlius to facilitate...
Abaxx Granted Approved Clearinghouse and Recognised Market Operator Licenses from Monetary Authority of Singapore
07 déc. 2023 08h45 HE
|
Abaxx Technologies Inc.
TORONTO, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Abaxx Technologies Inc. (NEO:ABXX)(OTCQX:ABXXF) (“Abaxx” or the “Company”), a financial software and market infrastructure company, majority shareholder of...
Adeia to Release Third Quarter 2023 Financial Results on November 6, 2023
16 oct. 2023 16h05 HE
|
Adeia Inc.
Adeia's third quarter earnings date annoucement